{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:39:00Z","timestamp":1793709540429,"version":"4.6.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014943","name":"Sarepta Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijid.2026.109144","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:43:24Z","timestamp":1790351004000},"page":"109144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["2-deoxy-D-glucose in a human rhinovirus challenge model: A randomized, double-blind placebo-controlled phase 2a clinical trial"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5529-2839","authenticated-orcid":false,"given":"Victor M.","family":"Cnossen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Assil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke L.","family":"de Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meta","family":"Roestenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Dorothea","family":"Gorki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald B.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido A.","family":"Gualdoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9440-3617","authenticated-orcid":false,"given":"Ingrid M.C.","family":"Kamerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9351","key":"10.1016\/j.ijid.2026.109144_bib0001","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(03)12162-9","article-title":"The common cold","volume":"361","author":"Heikkinen","year":"2003","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijid.2026.109144_bib0002","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1128\/jcm.35.11.2864-2868.1997","article-title":"Frequency and natural history of rhinovirus infections in adults during autumn","volume":"35","author":"Arruda","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ijid.2026.109144_bib0003","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-065X.2011.01031.x","article-title":"Rhinoviruses, allergic inflammation, and asthma","volume":"242","author":"Gavala","year":"2011","journal-title":"Immunol Rev"},{"issue":"9309","key":"10.1016\/j.ijid.2026.109144_bib0004","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(02)07953-9","article-title":"Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study","volume":"359","author":"Corne","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ijid.2026.109144_bib0005","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.ijid.2026.109144_bib0006","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1164\/rccm.200604-489OC","article-title":"Chronic rhinoviral infection in lung transplant recipients","volume":"174","author":"Kaiser","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ijid.2026.109144_bib0007","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/thoraxjnl-2018-212212","article-title":"Respiratory syncytial virus (RSV): a scourge from infancy to old age","volume":"74","author":"Coultas","year":"2019","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ijid.2026.109144_bib0008","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1128\/AAC.39.2.290","article-title":"Intranasal pirodavir (R77,975) treatment of rhinovirus colds","volume":"39","author":"Hayden","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.ijid.2026.109144_bib0010","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1128\/AAC.47.12.3907-3916.2003","article-title":"Phase II, randomized, double-blind, placebo-controlled studies of Ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers","volume":"47","author":"Hayden","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ijid.2026.109144_bib0012","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1164\/rccm.201312-2235OC","article-title":"The effect of inhaled IFN-\u03b2 on worsening of asthma symptoms caused by viral infections. A randomized trial","volume":"190","author":"Djukanovi\u0107","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.ijid.2026.109144_bib0013","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/jamainternmed.2016.5664","article-title":"Azithromycin for acute exacerbations of asthma: the AZALEA randomized clinical trial","volume":"176","author":"Johnston","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ijid.2026.109144_bib0014","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2147\/JEP.S255211","article-title":"Experimental antiviral therapeutic studies for Human rhinovirus infections","volume":"13","author":"Coultas","year":"2021","journal-title":"J Exp Pharmacol"},{"issue":"3","key":"10.1016\/j.ijid.2026.109144_bib0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.anorl.2012.09.005","article-title":"Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel","volume":"130","author":"Mortuaire","year":"2013","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"30","key":"10.1016\/j.ijid.2026.109144_bib0016","doi-asserted-by":"crossref","first-page":"E7158","DOI":"10.1073\/pnas.1800525115","article-title":"Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication","volume":"115","author":"Gualdoni","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.ijid.2026.109144_bib0017","article-title":"Host-directed therapy with 2-deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2","volume":"8","author":"Wali","year":"2022","journal-title":"J Virus Erad"},{"key":"10.1016\/j.ijid.2026.109144_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2018.00297","article-title":"Controlled Human infections As a tool to reduce uncertainty in clinical vaccine development","volume":"5","author":"Roestenberg","year":"2018","journal-title":"Front Med"},{"issue":"19","key":"10.1016\/j.ijid.2026.109144_bib0019","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/jama.281.19.1797","article-title":"Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus InfectionA randomized clinical trial","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2026.109144_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101224","article-title":"Effect of bifidobacterium animalis spp. Lactis bl-04 on rhinovirus-induced colds: a randomized, placebo-controlled, single-center, phase II trial in healthy volunteers","volume":"43","author":"Turner","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"4","key":"10.1016\/j.ijid.2026.109144_bib0021","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa044441","article-title":"An evaluation of echinacea angustifolia in experimental rhinovirus infections","volume":"353","author":"Turner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.109144_bib0022","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7326\/0003-4819-53-4-719","article-title":"Susceptibility and immunity to common upper respiratory viral infections\u2013the common cold","volume":"53","author":"Jackson","year":"1960","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ijid.2026.109144_bib0023","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2105\/AJPH.52.6.940","article-title":"VII. Present concepts of the common cold","volume":"52","author":"Jackson","year":"1962","journal-title":"Am J Public Health Nations Health"},{"issue":"6","key":"10.1016\/j.ijid.2026.109144_bib0024","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jclinepi.2004.11.019","article-title":"The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid","volume":"58","author":"Barrett","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.ijid.2026.109144_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1477-7525-7-76","article-title":"Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21)","volume":"7","author":"Barrett","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ijid.2026.109144_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107069","article-title":"Safety, tolerability, and pharmacokinetics of intranasal 2-deoxy-D-glucose in normal healthy volunteers: a randomized, double-blind, placebo-controlled, single and multiple ascending dose phase 1 study","volume":"209","author":"Bischof","year":"2025","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ijid.2026.109144_bib0027","first-page":"256","article-title":"Updated recommendations for safety-testing of viral inocula used in volunteer experiments on rhinovirus colds","volume":"39","author":"Gwaltney","year":"1992","journal-title":"Prog Med Virol Fortschritte Med Virusforsch Progres En Virol Medicale"},{"issue":"2","key":"10.1016\/j.ijid.2026.109144_bib0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM198601093140201","article-title":"Prophylactic efficacy of Intranasal Alpha2-interferon against rhinovirus infections in the Family setting","volume":"314","author":"Douglas","year":"1986","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijid.2026.109144_bib0029","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/infdis\/148.3.543","article-title":"Intranasal interferon \u03b12 for prevention of rhinovirus infection and illness","volume":"148","author":"Hayden","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.109144_bib0030","article-title":"From setbacks to success: lessons from the journey of RSV vaccine development","volume":"12","author":"Cnossen","year":"2024","journal-title":"Ther Adv Vaccines Immunother"},{"issue":"3","key":"10.1016\/j.ijid.2026.109144_bib0031","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jdv.15872","article-title":"Mobile e-diary application facilitates the monitoring of patient-reported outcomes and a high treatment adherence for clinical trials in dermatology","volume":"34","author":"Rijsbergen","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.ijid.2026.109144_bib0032","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1365-2273.2002.00589.x","article-title":"A study of intranasal distribution of azelastine hydrochloride aqueous nasal spray with different spray techniques","volume":"27","author":"Bateman","year":"2002","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.ijid.2026.109144_bib0033","series-title":"Rhinovirus Infections","first-page":"1","article-title":"Rhinovirus structure, replication, and classification","author":"Esneau","year":"2019"},{"issue":"3","key":"10.1016\/j.ijid.2026.109144_bib0034","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/infdis\/125.3.243","article-title":"Relation between naturally acquired immunity and infectivity of two rhinoviruses in volunteers","volume":"125","author":"Hendley","year":"1972","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.109144_bib0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcv.2015.03.013","article-title":"Prospective evaluation of rhinovirus infection in healthy young children","volume":"66","author":"Principi","year":"2015","journal-title":"J Clin Virol"},{"issue":"7","key":"10.1016\/j.ijid.2026.109144_bib0036","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/infdis\/jix685","article-title":"Asymptomatic summertime shedding of respiratory viruses","volume":"217","author":"Shaman","year":"2018","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2026.109144_bib0037","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1473-3099(15)00068-7","article-title":"Design, recruitment, and microbiological considerations in human challenge studies","volume":"15","author":"Darton","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.109144_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2025.101818","article-title":"Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies: a stakeholder meeting report","volume":"90","author":"Meln","year":"2025","journal-title":"Biologicals"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226007794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226007794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:20:45Z","timestamp":1793708445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226007794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":36,"alternative-id":["S1201971226007794"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109144","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2-deoxy-D-glucose in a human rhinovirus challenge model: A randomized, double-blind placebo-controlled phase 2a clinical trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"109144"}}